At HLTH 2025, Ian Khan sits down with Jenna DiRito of Revalia Bio to explore how human-organ-based “human data trials” are transforming drug discovery and medical device development. Jenna explains how her team revives donated organs and harnesses them for cutting-edge research—generating real human data safely, before patient trials begin. They discuss the challenges of traditional models, the role of scale in human data, and the future of healthcare innovation.

Jenna DiRito, PhD, is Co-Founder and Chief Operating Officer at Revalia Bio. With deep expertise in human organ research operations, she has helped build the infrastructure that turns declined transplant organs into high-fidelity research models—enabling human data trials that reduce risk and speed up the path to clinical impact. Her leadership is helping define a new era in preclinical medicine, where human-relevant data takes center stage.

Ian Khan is a globally recognised emerging tech leadership expert. A practising Futurist, Creator of the Future Readiness Leaders Circle, Multiple times author including "Metaverse for Dummies", Filmmaker and Storyteller on PrimeVideo and Emirates Airlines, one of the worlds largest airlines with 10 Million passengers per year. Ian's ground breaking work has been featured on CNN, the BBC, Fox, Bloomberg, Wharton Daily, ArabNews, RT, CoinBase, Korea Times, Spanish Daily Expansión, Ian hosts the worlds largest Future Readiness leadership networks, bringing together high performance entrepreneurs and leaders on a common mission to build future ready and undisputable businesses. Khan's new book is titled "Undisruptable" and is scheduled to release in early 2024.

Visit Ian at www.IanKhan.com